Business
WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS FERMENTATION MANUFACTURING NETWORK AND PROGRESS ON ITS CBG GRAS DETERMINATION
WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS FERMENTATION MANUFACTURING NETWORK AND PROG...
About this update from Atlas Energy Corp.
[{"type":"text","content":"\n \n \n \n WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS FERMENTATION MANUFACTURING NETWORK AND PROGRESS ON ITS CBG GRAS DETERMINATION\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n VANCOUVER, BC\n \n \n ,\n \n \n May 11, 2022\n \n \n /CNW/ - Willow Biosciences Inc. (\"\n \n Willow\n \n \" or the \"\n \n Company\n \n \") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of high-value molecules traditionally derived from plants, announces expanded production capacity with a new manufacturing partnership and progress with respect to its Generally Recognized as Safe (\"\n \n GRAS\n \n \") determination.\n \n \n \n \n \n \n \n \n \n \n Expansion of Fermentation Manufacturing Network\n \n \n \n Willow is pleased to announce the signing of a Manufacturing Services Agreement (\"\n \n MSA\n \n \") with a second Contract Development and Manufacturing Organization (\"\n \n CDMO\n \n \"), which will offer increased fermentation capacity to produce Willow's FutureGrown™ products, including cannabigerol (\"\n \n CBG\n \n \"). Willow's new partner has a strong track record in the large-scale production of food, nutritional, and pharmaceutical products and holds all necessary certifications to serve these markets. This new CDMO partnership allows Willow to accommodate new programs, both internal and partnered, in addition to its cannabinoid portfolio.\n \n \n Willow's Chief Operating Officer Dr.\n \n Chris Savile\n \n noted, \"with the unprecedented demand for precision fermentation assets, having a global network of CDMOs with diverse capabilities is an absolute requirement. The addition of this premier CDMO with large scale fermentation assets will ensure Willow's manufacturing capabilities can readily expand to meet market demand.\"\n \n \n \n Successful Completion of Initial Toxicological Assessment for GRAS Determination\n \n \n \n Willow has successfully completed the Stage 1 toxicological assessment of its FutureGrown™ CBG pr...